from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1219c/-

LFCtreatmentdescriptionclass of inhibitor

-0.340

Amikacinug/mL Amikacintranslation

-0.121

Cap5-10ug/mL Capreomycintranslation

0.125

Rox10-50 ug/mL Roxithromycintranslation

0.129

SM2-5 ug/mL Streptomycintranslation

-0.121

Tet5-10 ug/mL Tetracyclinetranslation

-0.550

Rif0.2-5ug/mL Rifampicintranscription

-0.759

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.436

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.473

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.006

CPZ10-50 ug/mL Chlorpromazinerespiration

0.570

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.146

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.804

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.728

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.005

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.050

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.442

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.367

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.012

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.037

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.910

KCN5-20 ug/mL Potassium cyaniderespiration

-0.478

NaN30.2-2 mM Sodium aziderespiration

6.387

Nigericin50 uM Nigericinrespiration

-0.326

TRC10-150 ug/mL Triclosanrespiration

0.677

TRZ10-25 ug/mL Thioridazinerespiration

2.438

Valinomycin0.5-10 uM Valinomycinrespiration

-1.697

ZnSO42 mM ZnSO4respiration

0.056

menadione6-10 ug/mL Menadionerespiration

0.379

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.408

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.162

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.330

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.709

NRP_1Non-replicating persistence stage 1dosRassociated

-0.358

Amp0.2mg/mL AmpicillincellWall

-0.522

Cephalexin20-100 ug/mL CephalexincellWall

-0.335

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.187

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.237

EMB10-20 ug/mL EthambutolcellWall

-0.396

Eta12-40 ug/mL EthionamidecellWall

-0.413

INH0.2-0.4 ug/mL IsoniazidcellWall

0.852

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.969

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.759

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.055

BZA0.12 mg/mL BenzamidearomaticAmides

-0.740

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.024

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.606

H2O24 mM hydrogen peroxideDNAdamaging

-0.440

Levo10 ug/mL LevofloxacinDNAdamaging

-0.716

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.356

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.349

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.400

UVUV-irradiationDNAdamaging

0.332

ARP41-4 ug/mL Antitubercular compound ARP4?

0.359

Antimycin12.5-50 ug/mL Antimycin A?

-0.057

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.058

PA_110-50 ug/mL Antitubercular compound PA-1?

0.035

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.187

PA8240.2-2 ug/mL PA-824?

-0.284

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.281

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.711

Verapamil50 uM Verapamil?

-0.293

mercaptoethanol2 mM 2-Mercaptoethanol?

1.514

methoxatin10-20 ug/mL Methoxatin?